Insider Stock Trading History of Silverstein Jonathan


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Silverstein Jonathan since year 2005. The trader's CIK number is 1171005. At the time of this reporting, Silverstein Jonathan is the of Glaukos Corp . (stock ticker symbol GKOS). See this page for all insider trading activities at Glaukos Corp .

Note that in the past SILVERSTEIN JONATHAN also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Silverstein Jonathan since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-09-01 GKOS Glaukos Corp Sale 110,078 37.72 4,152,142
2017-08-31 GKOS Glaukos Corp Sale 44,922 37.82 1,698,950
2017-09-05 GKOS Glaukos Corp Sale 425,200 39.45 16,772,864
2017-08-17 GKOS Glaukos Corp Sale 226,920 37.85 8,588,922
2017-08-16 GKOS Glaukos Corp Sale 65,580 38.01 2,492,695
2017-08-15 GKOS Glaukos Corp Sale 32,500 38.29 1,244,425
2017-03-10 GKOS Glaukos Corp Sale 97,028 45.98 4,461,347
2017-03-13 GKOS Glaukos Corp Sale 211,410 45.72 9,664,608
2017-03-14 GKOS Glaukos Corp Sale 74,100 44.54 3,300,414
2017-03-03 GKOS Glaukos Corp Sale 55,772 47.05 2,624,072
2016-08-10 GKOS Glaukos Corp Sale 117,938 33.77 3,982,766
2016-08-12 GKOS Glaukos Corp Sale 14,100 33.72 475,452
2016-08-11 GKOS Glaukos Corp Sale 160,900 33.63 5,411,067
2016-08-03 GKOS Glaukos Corp Sale 425,000 30.59 13,000,750
2016-07-25 BOLD Audentes Therapeutics, Inc. Buy 33,334 15.00 500,010
2015-06-30 GKOS Glaukos Corp Option Ex 27,607 .00 0
2015-03-26 ICPT Intercept Pharmaceuticals Inc Sale 157,200 287.71 45,228,797
2015-03-23 ICPT Intercept Pharmaceuticals Inc Sale 159,400 278.64 44,415,056
2015-03-24 ICPT Intercept Pharmaceuticals Inc Sale 45,600 271.80 12,394,034
2015-03-25 ICPT Intercept Pharmaceuticals Inc Sale 2,800 270.23 756,644
2014-08-25 ICPT Intercept Pharmaceuticals Inc Sale 50,000 296.01 14,800,500
2014-08-26 ICPT Intercept Pharmaceuticals Inc Sale 61,258 300.74 18,422,424
2014-08-14 ICPT Intercept Pharmaceuticals Inc Sale 60,000 300.36 18,021,780
2014-08-09 ICPT Intercept Pharmaceuticals Inc Option Ex 324 .00 0
2014-07-22 ROKA Roka Bioscience, Inc. Buy 383,333 12.00 4,599,996
2014-05-09 ICPT Intercept Pharmaceuticals Inc Option Ex 325 .00 0
2014-04-09 ICPT Intercept Pharmaceuticals Inc Sale 81,305 320.00 26,017,600
2014-02-09 ICPT Intercept Pharmaceuticals Inc Option Ex 324 .00 0
2013-11-20 RLYP Relypsa Inc Buy 712,192 11.00 7,834,112
2013-11-20 RLYP Relypsa Inc Option Ex 1,744,711 .17 296,600
2013-11-09 ICPT Intercept Pharmaceuticals Inc Option Ex 325 .00 0
2013-10-21 ICPT Intercept Pharmaceuticals Inc Sale 40,088 62.50 2,505,500
2013-10-15 ICPT Intercept Pharmaceuticals Inc Sale 376,585 62.50 23,536,562
2013-08-09 ICPT Intercept Pharmaceuticals Inc Option Ex 325 .00 0
2013-05-09 ICPT Intercept Pharmaceuticals Inc Option Ex 324 .00 0
2013-04-09 ICPT Intercept Pharmaceuticals Inc Option Ex 649 .00 0
2012-10-16 ICPT Intercept Pharmaceuticals Inc Buy 333,334 15.00 5,000,010
2006-05-31 AVNR Avanir Pharmaceuticals Sale 629,121 9.79 6,159,094
2005-10-20 AVN Avanir Pharmaceuticals Buy 566,038 2.65 1,500,000
2005-04-08 AVN Avanir Pharmaceuticals Buy 900,000 2.20 1,980,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Silverstein Jonathan ( of Glaukos Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.